Tcelltech Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies (NCT07485504) | Tcelltech Inc. | 2026-04-15 |
| Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas (NCT07052383) | Tcelltech Inc. | 2025-11-06 |
| Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors (NCT07231081) | Tcelltech Inc. | 2025-10-16 |
| Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma. (NCT06482905) | Tcelltech Inc. | 2024-09-04 |
Track Tcelltech Inc. automatically
Every clearance here is in the API, with alerts when new ones post.